Famotidine 40mg/5mL; pwd for reconstitution; cherry-banana-mint flavor. Famotidine is a competitive inhibitor of histamine-2 (H2) receptors. The primary clinically important pharmacologic activity ...
Famotidine is used to treat and prevent ulcers in the stomach and intestines. It also treats conditions in which the stomach produces too much acid, such as Zollinger-Ellison syndrome. Famotidine ...
The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...
Duloxetine (as HCl) 20mg, 30mg, 40mg, 60mg; del-rel caps ... History of seizure disorders, drug abuse. Angle-closure glaucoma. Decreased GI motility. Cardiac disease. Diabetes.
Amazon Fire tablet problems can arise for many reasons. Some common ones include the device freezing and not starting up, issues charging, audio problems, etc. Sometimes, a simple restart will fix ...
It belongs to the nonsteroidal anti-inflammatory drug (NSAID) class ... The maximum recommended dose is 40 mg/kg. An adult ...
Learn more› By Roderick Scott and Ryan Whitwam After a new round of testing, we’ve added the 2024 Amazon Fire HD 8 tablet as our budget pick and added Samsung’s Galaxy Tab S10+ to the ...
Tired of squinting at your phone, even though it's one of the best? A tablet might be the perfect solution. But with a dizzying array of options available, finding the right one can be tough.
This is not meant to be a complete dosage guide. Duodenal (Intestinal) Ulcer 20 mg once daily Four weeks; can repeat four weeks if needed Gastric (Stomach) Ulcer 40 mg once daily Four to eight weeks ...
The difference between a good tablet and a bad one can be stark. Our tough independent tests weed out the models to avoid and our expert buying advice will help you choose a winner. Use the results of ...
Learn more› By Roderick Scott, Dave Gershgorn and Nick Guy Apple just announced its new $500 iPad mini tablet. We plan to test it soon, and you can read more details in our What to look forward ...